Position in QGEN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$178,822,090
+$23,927,791 QoQ
Shares Held
4,573,455
+18.2% QoQ
Ownership
2.21%
of shares outstanding
% of Portfolio
0.65%
of 13F equity value
Holder Rank
#7
of 332 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 70%
Shared 15%
None 14%
Common Shares in QGEN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026EARNEST PARTNERS LLC holds $949,661,041 across 7 Diagnostics & Research names. QGEN ranks #3 (18.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRL |
Charles River Laboratories International, Inc.
|
1,120,011 | $254,007,294 | |
| 2 | ICLR |
Icon PLC
|
1,242,639 | $215,858,820 | |
| 3 | QGEN |
Qiagen N.V.
This page
|
4,573,455 | $178,822,090 | |
| 4 | LH |
Labcorp Holdings Inc.
|
476,506 | $133,421,680 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
548,088 | $105,901,563 | |
| 6 | A |
Agilent Technologies, Inc.
|
451,170 | $59,928,911 | |
| 7 | WAT |
Waters Corp /De/
|
4,588 | $1,720,683 |
All Filings in QGEN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $178,822,090 | 4,573,455 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $154,894,299 | 3,868,489 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $188,329,098 | 4,187,883 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $188,030,865 | 4,208,390 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $201,960,183 | 4,202,251 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $152,837,880 | 3,806,672 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $178,230,835 | 4,002,489 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $179,450,740 | 3,937,914 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $156,441,299 | 3,807,284 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $147,352,738 | 3,427,605 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $82,976,216 | 1,851,346 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $63,174,325 | 1,511,503 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $65,404,302 | 1,407,434 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $7,204 | 152 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,822 | 152 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $6,475 | 152 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,403 | 152 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $7,686 | 152 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $8,718 | 152 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $8,106 | 152 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,589 | 152 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $7,637 | 152 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $8,290 | 152 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $8,197 | 152 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $6,715 | 152 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $6,697 | 156 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||